Harrow Health Inc (HROW)
US$ 00%
Price Chart
Key Statistics
Market Cap
$ 1.59B
P/E Ratio
0.00
Revenue (TTM)
$ 227.66M
Volume
0
52W High
$ 59.23
52W Low
$ 20.85
Dividend Yield
0.00%
Beta
0.33
Technicals
50-Day MA
36.423
200-Day MA
31.4806
52 Week High
59.23
52 Week Low
20.85
About HROW
Harrow, Inc., an eyecare pharmaceutical company, engages in the discovery, development, and commercialization of ophthalmic pharmaceutical products.
Employees
382
Headquarters
Nashville, TN
CEO
Mr. Mark L. Baum J.D.